Search
Mckesson Corp
MCKAdd to Watchlist
750.630USD
-29.000-3.72%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
87.88BMarket Cap
19.48P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Mckesson Corp is 8.63, ranking 24 out of 157 in the Pharmaceuticals industry. The average price target is 955.00, with a high of 1000.00 and a low of 757.50.
Analyst Rating
Based on
19
analysts
Buy
Current Rating
932.815
Target Price
+24.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Mckesson Corp
MCK
19
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Mckesson Corp's expected revenue for the next quarter?
Mckesson Corp's expected revenue is 104.00B.
What is Mckesson Corp's price target?
Analysts forecast that Mckesson Corp's price target is USD 955.00, with the highest forecast at USD 1.00K and the lowest forecast at USD 757.50.
How have Mckesson CorpMCK's recent earnings per share performed?
The market expectation was USD 13.74, while Mckesson CorpMCK's earnings per share (EPS) for the previous quarter was USD 9.63. EPS for the next quarter is expected at USD 9.63.
What is the analyst rating for Mckesson Corp?
Based on the ratings of Mckesson Corp's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
